TherapeuticsMD
TXMD
TXMD
44 hedge funds and large institutions have $19.4M invested in TherapeuticsMD in 2022 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 11 increasing their positions, 8 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
44
Holders Change
+1
Holders Change %
+2.33%
% of All Funds
0.71%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
11
Reduced
8
Closed
9
Calls
$1.6M
Puts
$2.86M
Net Calls
-$1.26M
Net Calls Change
-$133K
Top Buyers
| 1 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$3.36M |
| 2 |
CC
Clearline Capital
New York
|
+$1.31M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$698K |
| 4 |
BlackRock
New York
|
+$645K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$374K |
Top Sellers
| 1 |
JGC
J. Goldman & Co
New York
|
-$388K |
| 2 |
Millennium Management
New York
|
-$387K |
| 3 |
Stifel Financial
St. Louis,
Missouri
|
-$113K |
| 4 |
AMG
Asset Management Group
Stamford,
Connecticut
|
-$98K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$68.5K |
